학술논문
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Document Type
Article
Author
Joly, P.; Maho-Vaillant, M.; Hebert, V.; Calbo, S.; Caillot, F.; Golinski, M.L.; Duvert-Lehembre, S.; Musette, P.; Prost-Squarcioni, C.; Caux, F.; Alexandre, M.; Houivet, E.; Benichou, J.; Labeille, B.; Picard-Dahan, C.; Paul, C.; Richard, M.-A.; Bouaziz, J.D.; Bernard, P.; Ingen-Housz-Oro, S.; Vabres, P.; Delaporte, E.; Quereux, G.; Dupuy, A.; Debarbieux, S.; Avenel-Audran, M.; D'Incan, M.; Bedane, C.; Bénéton, N.; Jullien, D.; Dupin, N.; Misery, L.; Machet, L.; Beylot-Barry, M.; Dereure, O.; Sassolas, B.; Vermeulin, T.
Source
In: The Lancet . (The Lancet, 20 May 2017, 389(10083):2031-2040)
Subject
Language
English
ISSN
1474547X
01406736
01406736